Furthermore, in advanced NSCLC recent findings identified a novel relationship between EGFR oncogene activation, over-expression of immunosuppressive molecule such as CD73 and reduced expression of IFNγ signature, and this may explain, at least in part, the limited responsiveness to immunotherapy in EGFR-mutated NSCLC. Here, IFNG is linked to non-small cell lung carcinoma.